About Firefly BioWorks
Firefly BioWorks is a Healthcare company based in Cambridge (United States) founded in 2010, and was acquired by Abcam in January 2015. It develops platform to allow multiplexed assays on standard laboratory instrumentation. Firefly BioWorks has raised $2.77 million across 6 funding rounds from investors including Abcam, HHS and Massachusetts Life Sciences Center. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include GenScript, OriGene and Meridian Bioscience; 2 of its 3 listed competitors have raised funding.
Company details
Firefly BioWorks was founded in 2010 in Cambridge, United States, within the biotechnology sector. An open platform is offered to industrial, academic, and clinical scientists for developing and using multiplexed biological assays on standard laboratory equipment. Core technology, known as Optical Liquid Stamping, is utilized for synthesizing encoded, multi-functional particles to quantify biological functions. Reliable solutions are focused on for monitoring biological systems in research and clinical settings.
- Headquarters Cambridge, United States
- Stage Acquired
- SectorsHealthcare
- Website fireflybio.com
- Social LinkedIn X
- Acquired by Abcam (Jan 2015)
Funding Insights of Firefly BioWorks
Firefly BioWorks has successfully raised a total of $2.77M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $775 thousand completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.77M
- Total Rounds 6
- Last Round Series A — $775,000
- First Round $249,885
(Jun 2009)
- Investors Count 2
All 6 funding rounds of Firefly BioWorks with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2014 | $775,000 | Series A | – | – | – |
| Apr 2013 | $120,000 | Grant | – | – | – |
| May 2012 | $500,000 | Grant | – | – | |
| Oct 2011 | $2M | Series A | – | – | – |
| Mar 2010 | $176,400 | Grant | – | – | |
| Jun 2009 | $249,885 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Firefly BioWorks
Firefly BioWorks has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Abcam, HHS and Massachusetts Life Sciences Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life sciences innovation is supported through funding and programs. | masslifesciences.com | Waltham, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Biological reagents and antibodies are developed for life science research. | 1998 | abcam.com | Cambridge, United Kingdom |
Investor details for Firefly BioWorks
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Firefly BioWorks
4 dated milestones of Firefly BioWorks across 6 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round of $250K.
- Founded Firefly BioWorks is founded.
- Funding Latest funding round, Series A, of $775K.
- Exit Acquired by Abcam.
Competitors of Firefly BioWorks
Firefly BioWorks has 3 listed competitors in our database, 2 of them funded. They include GenScript, OriGene and Meridian Bioscience.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits |
Detailed competitors of Firefly BioWorks
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Firefly BioWorks (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Firefly BioWorks
Firefly BioWorks was founded in 2010.
Firefly BioWorks is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Firefly BioWorks is a funded company, having raised a total of $2.77M across 6 funding rounds to date. The company's 1st funding round was a Grant of $249.89K, raised on Jun 2009.
Firefly BioWorks was founded in 2010 in Cambridge, United States, within the biotechnology sector. An open platform is offered to industrial, academic, and clinical scientists for developing and using multiplexed biological assays on standard laboratory equipment. Core technology, known as Optical Liquid Stamping, is utilized for synthesizing encoded, multi-functional particles to quantify biological functions. Reliable solutions are focused on for monitoring biological systems in research and clinical settings.
Firefly BioWorks's top competitors include Meridian Bioscience, GenScript and OriGene.
Firefly BioWorks has 3 investors. Key investors include Abcam, HHS, and Massachusetts Life Sciences Center.
Yes. Firefly BioWorks was acquired by Abcam in January 2015.